NovaSignal Corp. recalls Lucid TCD 2.0 System, Model: NA-LUCM1. Transcranial Ultrasound System
- Recall date
- December 16, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1049-2023
- FDA classification
- Class II
- Brand / firm
- NovaSignal Corp.
- Sold / distributed
- US Nationwide and Worldwide Distribution: AZ, TX, SC, PA, IL. OUS: CA, SE, NL
Why it was recalled
Transcranial Doppler/ultrasound system tablet has a faulty hard drive, which will cause the system to freeze and reboot. Initially, the system will reboot to a normal operable state but eventually the system will be rendered inoperable.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lucid TCD 2.0 System, Model: NA-LUCM1. Transcranial Ultrasound System
Get recall alerts
Free email alert whenever NovaSignal Corp. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: NovaSignal Corp.